We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMI icon
451
Cummins
CMI
$83.6B
$3.58M 0.02%
15,949
-6,152
-28% -$1.44M
ALL icon
452
Allstate
ALL
$70.6B
$3.55M 0.02%
27,907
-5,609
-17% -$741K
NIO icon
453
NIO
NIO
$11.9B
$3.54M 0.02%
99,503
-718,413
-88% -$29.5M
RJF icon
454
Raymond James Financial
RJF
$33.5B
$3.54M 0.02%
38,356
-2,111
-5% -$189K
YETI icon
455
Yeti Holdings
YETI
$3.87B
$3.5M 0.02%
40,839
+3,470
+9% +$336K
BNY
456
Bank of New York Mellon
BNY
$103B
$3.48M 0.02%
67,220
-772
-1% -$40.1K
DEO icon
457
Diageo
DEO
$49.6B
$3.48M 0.02%
18,046
– –
FDX icon
458
FedEx
FDX
$73B
$3.48M 0.02%
15,869
-6,338
-29% -$1.72M
PCAR icon
459
PACCAR
PCAR
$70.5B
$3.46M 0.02%
65,841
+1,491
+2% +$82.7K
ED icon
460
Consolidated Edison
ED
$41.4B
$3.46M 0.02%
47,642
+2,736
+6% +$204K
FITB
461
Fifth Third Bancorp
FITB
$51.3B
$3.43M 0.02%
80,915
-58,217
-42% -$2.23M
TROW icon
462
T. Rowe Price
TROW
$25.5B
$3.38M 0.02%
17,179
-12,457
-42% -$2.62M
IT icon
463
Gartner
IT
$11.1B
$3.36M 0.02%
+11,069
New +$3.21M
PHAS
464
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$3.36M 0.02%
1,081,258
+461,824
+75% +$1.54M
TRU icon
465
TransUnion
TRU
$16B
$3.35M 0.02%
29,875
+15,136
+103% +$1.78M
IBN icon
466
ICICI Bank
IBN
$107B
$3.31M 0.02%
175,250
-826,071
-82% -$15.5M
SNBR
467
DELISTED
Sleep Number
SNBR
$3.3M 0.02%
35,272
+6,912
+24% +$686K
WRB icon
468
W.R. Berkley
WRB
$28.1B
$3.26M 0.02%
100,265
+84,308
+528% +$2.78M
IFF icon
469
International Flavors & Fragrances
IFF
$20.3B
$3.25M 0.02%
24,332
-1,851
-7% -$272K
ROP icon
470
Roper Technologies
ROP
$40.4B
$3.25M 0.02%
7,285
-1,416
-16% -$678K
SYY icon
471
Sysco
SYY
$40.8B
$3.23M 0.02%
41,127
+6,983
+20% +$533K
WBA
472
DELISTED
Walgreens Boots Alliance
WBA
$3.22M 0.02%
68,530
+5,602
+9% +$270K
DNLI icon
473
Denali Therapeutics
DNLI
$3.79B
$3.22M 0.02%
63,781
– –
KOD icon
474
Kodiak Sciences
KOD
$2.5B
$3.19M 0.02%
33,186
– –
ES icon
475
Eversource Energy
ES
$28.1B
$3.17M 0.02%
38,799
-719
-2% -$62.4K
17 18
19
20 21

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.